Clinical Trials Browser

Interventional × Neoplasms × gp100 Melanoma Antigen × Clear all

NCT00960752 2021-08-13

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Phase 2 Completed

47 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Neoplasms